Go to JAX® Mice Query Form

Strain Name:

B6;129S7-Cyp7a1tm1Rus/J

Stock Number:

002751

Availability:

Repository-Cryopreserved


General Terms and Conditions

Genes & Alleles   Cyp7a1;   Cyp7a1tm1Rus;


Product Information

Strain Details

Type JAX® GEMM® Strain - Mutant Stock
Additional information on JAX® GEMM® Strains.
Type JAX® GEMM® Strain - Targeted Mutation
Specieslaboratory mouse
Donating Investigator David Russell,   Univ of Texas Southwest Med Ctr Dallas
GenerationN1

Appearance
black
Related Genotype: a/a

Strain Description
Heterozygous carriers of the disrupted Cyp7a1 gene are phenotypically normal, viable, and fertile. Homozygous animals appear normal at birth but most die within the first 18 days of life. The 10-15% of homozygotes that survive are fertile. Newborn animals with a homozygous mutation in the Cyp7a1 gene lack bile acids, causing fat malabsorption as manifest by severe steatorrhea (fatty stools), deficiency of fat-soluble vitamins, and wasting due to malnutrition. Approximately 40% of the homozygotes die between postnatal days 1-4; 45% between days 11-18. Vitamin supplements given to nursing mothers can prevent deaths during the early period; cholic acid supplements in the mother's diet can prevent deaths in the later period. Mutant pups born to homozygous mothers not maintained on dietary supplements are noticeably smaller than age-matched heterozygous and wild type siblings. The skin of nursing homozygotes can be dry and scaly in appearance. Nursing heterozygous and homozygous mothers and their mutant pups not treated with cholic acid develop an unusually oily coat. No immunoreactive or enzymatically active Cyp7a1 proteins are produced in homozygous mutants, but a novel "hybrid" mRNA present in heterozygous and homozygous animals is composed of sequences derived from the 5' and 3' ends of the mutated gene.

Strain Development
Disruption of the murine Cyp7a1 gene was carried out in AB-1 embryonic stem cells (derived from the 129S5/SvEvBrd strain) which were injected into C57BL/6J blastocysts. A neomycin cassette replaces most of exon 3, and all of exons 4 and 5 of the gene.

Mammalian Phenotype Terms assigned by genotype

Cyp7a1tm1Rus/Cyp7a1tm1Rus

        involves: 129S7/SvEvBrd * C57BL/6J
  • lethality-prenatal/perinatal
  • perinatal lethality (J:34342)
    • homozygotes born in expected numbers
    • high rate of mortality when mothers fed a normal diet
  • lethality-postnatal
  • postnatal lethality (J:34342)
    • without dietary supplementation, 85% die within the first 18 days postnatally
    • perinatal lethality extends through day 4 and results in 40% mortality
    • further mortality occurs after age 11 days and results in a total postnatal lethality of 85%
    • supplementation with vitamins and cholic acid begun at E12 results in normal survival
  • growth/size phenotype
  • abnormal prenatal growth/weight/body size (J:34342)
    • pups noticably smaller than normal when maternal diet has not been supplemented
  • postnatal growth retardation (J:34342)
    • slow growth to 5 days then very little growth to day 11 when maternal diet is not supplemented
  • homeostasis/metabolism phenotype
  • abnormal bile salt homeostasis (J:34342)
    • cholic acid supplementation of maternal diet has no affect on early deaths but prevents later ones
    • abnormal bile salt level (J:34870)
      • reduced levels of bile acids in stools
  • abnormal fat-soluble vitamin level (J:34342)
    • supplementation with vitamins and cholic acid begun at E12 results in normal survival
    • vitamins in water reduces early wave of deaths but has no affect on later deaths
    • supplementation begun at birth still results in 60% mortality before age 14 days
    • reduced tissue levels of vitamins D3 and E, improved to varying degrees by vitamin and cholic acid supplementation
  • abnormal lipid homeostasis (J:34870)
    • secretion of a mixture of monoglyeride esters causes oil coat of nursing females and oily skin of nursing pups
    • decreased cholesterol absorption (J:114411)
      • nearly absent
  • digestive/alimentary phenotype
  • decreased cholesterol absorption (J:114411)
    • nearly absent
  • steatorrhea (J:34342)
    • pups produce fatty stools
  • skin/coat/nails phenotype
  • abnormal skin condition/ morphology (J:34342)
    • abnormal skin condition (J:34342)
      • dry skin (J:34342)
        • on 5 day pups
      • flaky skin (J:34342)
        • on 5 day pups
      • oily skin (J:34342)
        • nursing pups develop an oily skin and usually die
        • skin becomes "normal" after 7 days
    • abnormal skin morphology (J:34342)
      • abnormal basal cell layer morphology (J:34342)
        • compressed
      • abnormal granular layer morphology (J:34342)
        • thickened
      • hyperkeratosis (J:34342)
        • cornified layer of the epidermis is thickened
      • thin dermal layer (J:34342)
        • compressed
      • thin epidermal spinous layer (J:34342)
        • compressed
  • greasy coat (J:34342)
    • nursing homozygous (and heterozygous) mothers develop a very oily coat which lasts for a minimum of 7 and up to 14 days
  • vision/eye phenotype
  • abnormal vision (J:34342)
    • reduced exploratory behavior after openning of eyelids suggestive of reduced vision
  • delayed eyelid opening (J:34342)
    • eyelid openning 8-9 days later than normal
    • excessive secretions from between the lids
  • behavior/neurological phenotype
  • decreased exploration in new environment (J:34342)
  • hypoactivity (J:34342)
    • reduced exploratory behavior after opening of eyelids suggestive of reduced vision
  • liver/biliary system phenotype
  • abnormal bile composition (J:34870)
    • reduced cholic acid in bile relative to controls while some other bile acids are elevated
  • abnormal liver morphology (J:34342)
    • yellow crystalline deposits in the liver
  • abnormal liver physiology (J:34342)
    • increased conjugated bilirubin

Gene & Allele Details

Allele Symbol Cyp7a1tm1Rus
Allele Name targeted mutation 1, David W Russell
Common Name(s) CYP7A1-; Cyp7-;
Mutation Made By David Russell,   Univ of Texas Southwest Med Ctr Dallas
Strain of Origin129S7/SvEvBrd-Hprt1<+>
ES Cell Line NameAB1
ES Cell Line Strain129S7/SvEvBrd-Hprt1<+>
Gene Symbol and Name Cyp7a1, cytochrome P450, family 7, subfamily a, polypeptide 1
Chromosome 4
Gene Common Name(s) CHAP; CP7A; CYP7; CYP7S1; MGC126826; MGC138389; cholesterol 7 alpha hydroxylase;
Molecular Note A genomic fragment containing part of exon 3, exon 4 and exon 5 was replaced with a neomycin selection cassette. Activity assays on extracts of liver microsomal memebrane preparations derived from homozygous mice demonstrated that no functional protein is made from this allele. [J:34342]

Control Information

  Control
   101045 B6129SF2/J (approximate)
 
  Considerations for Choosing Controls

Genotyping Protocols

Cyp7a1tm1Rus

Colony Maintenance

Breeding & HusbandryThis strain requires a cholic acid dietary supplement. Cholic acid is mixed and fed with milled food at the concentration 1g cholic acid/100g milled food. A vitamin supplement may also be required. Mice from the B6129F2/J colony (Stock 101045) may be used as controls. The B6129F2/J mice only provide an approximate match to this B6,129 background. Expected coat color from breeding:Black
Diet Information LabDiet® 5K52/5K67

Research Applications

This mouse can be used to support research in many areas including:

Cyp7a1tm1Rus related

Cardiovascular Research
Other (altered fat metabolism)

Metabolism Research

References

Selected Reference(s)

Ishibashi S; Schwarz M; Frykman PK; Herz J; Russell DW. 1996. Disruption of cholesterol 7alpha-hydroxylase gene in mice. I. Postnatal lethality reversed by bile acid and vitamin supplementation. J Biol Chem 271(30):18017-23. [PubMed: 8663429]  [J:34342]

Additional References

Price and Supply Information

Strain Name: B6;129S7-Cyp7a1tm1Rus/J
Stock Number: 002751

Price Details

IMPORTANT NOTE: Prices are based on shipping destination. To view prices, select your shipping destination.

*NO Shipping Destination selected!

 

Supply Details

Standard SupplyRepository-Cryopreserved. Must Be Recovered. Please refer to the Supply Notes for further information.
Supply Notes Cryorecovery - Standard.
The recovery process begins when a signed agreement form is returned to the Customer Service Department after order placement. Although results vary by strain, at least two males and two females (two pairs) will be provided, typically within 15 weeks of our receipt of the signed agreement form. If the first recovery attempt is unsuccessful or only one pair is recovered, a second recovery will be done, extending the delivery time to approximately 25 weeks. At least one member of each pair will be of known genotype and will carry the mutation if it is a mutant strain. Please note that pairs may not reflect the mating scheme utilized by The Jackson Laboratory prior to cryopreservation of the strain. Mating schemes are sometimes modified for successful cryopreservation. Price represents a repository maintenance fee, which includes the cost of recovery of the strain from the cryopreservation resource and the periodic replacement of the frozen embryos used for recovery.

Cryorecovery to establish a Dedicated Supply for greater quantities of mice.
One to two pairs will be recovered to establish a Dedicated Supply of mice. Price by quotation. For more information on Dedicated Supply, please contact JAX® Services: Tel: 1-800-422-6423 or 1-207-288-5845; Email: jaxservices@jax.org.
This strain is included in the Induced Mutant Resource Colony collection.
Genomic DNA is available for this strain from the Mouse DNA Resource.

LicensingSee General Terms and Conditions below  
Control InformationView Control Information in Strain Details.

General Terms and Conditions

View JAX® Mice & Services Conditions of Use.

The Jackson Laboratory's Genotype Promise

The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project.
Ordering and Purchasing Information

      Purchasing Information
      JAX® Mice Orders
      Surgical Services

Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form

Go to JAX® Mice Query Form

(2.13)